Literature DB >> 21171956

Developments in high-yield system expressed vaccines and immunotherapy.

Marissa Geels1, Kaiming Ye.   

Abstract

Conventional vaccine production techniques are outdated, leaving the world defenseless to viruses and pathogens. Successful protection necessitates the innovation of strategies that can generate an induced defensive humoral and cellular response with: ease of mass production, nominal side-effects, and controlled design specificity, all while being cost effective. Fortunately, technology exists to facilitate such advances in this billion dollar industry and this review is focused on recent publications and patents which hold promise to revolutionize the fight against pathogenic illnesses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21171956      PMCID: PMC3020102          DOI: 10.2174/187220810793611518

Source DB:  PubMed          Journal:  Recent Pat Biotechnol        ISSN: 1872-2083


  24 in total

Review 1.  Microbial cell-surface display.

Authors:  Sang Yup Lee; Jong Hyun Choi; Zhaohui Xu
Journal:  Trends Biotechnol       Date:  2003-01       Impact factor: 19.536

2.  Surface-displayed viral antigens on Salmonella carrier vaccine.

Authors:  J S Lee; K S Shin; J G Pan; C J Kim
Journal:  Nat Biotechnol       Date:  2000-06       Impact factor: 54.908

3.  Simultaneous display of multiple foreign peptides in the FliD capping and FliC filament proteins of the Escherichia coli flagellum.

Authors:  Katariina Majander; Timo K Korhonen; Benita Westerlund-Wikström
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

4.  Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors.

Authors:  Anatoli Giritch; Sylvestre Marillonnet; Carola Engler; Gerben van Eldik; Johan Botterman; Victor Klimyuk; Yuri Gleba
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

5.  Quantitative analysis of influenza virus-specific B cell memory generated by different routes of inactivated virus vaccination.

Authors:  Hye Mee Joo; Yuxia He; Aarthi Sundararajan; Lifang Huan; Mark Y Sangster
Journal:  Vaccine       Date:  2010-01-05       Impact factor: 3.641

6.  The surface display of haemolysin from Vibrio harveyi on yeast cells and their potential applications as live vaccine in marine fish.

Authors:  Kailing Zhu; Zhenming Chi; Jing Li; Fengli Zhang; Meiju Li; Hirimuthugoda Nalini Yasoda; Longfei Wu
Journal:  Vaccine       Date:  2006-06-08       Impact factor: 3.641

7.  Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination.

Authors:  Beka Solomon
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

Review 8.  Progress towards recombinant anti-infective antibodies.

Authors:  Jennifer C Pai; Jamie N Sutherland; Jennifer A Maynard
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2009-01

9.  Engineering filamentous phage carriers to improve focusing of antibody responses against peptides.

Authors:  Nienke E van Houten; Kevin A Henry; George P Smith; Jamie K Scott
Journal:  Vaccine       Date:  2010-01-05       Impact factor: 3.641

10.  A universal anti-HIV-1 Tat epitope vaccine that is fully synthetic and self-adjuvanting.

Authors:  Gideon Goldstein; John J Chicca
Journal:  Vaccine       Date:  2009-12-01       Impact factor: 3.641

View more
  1 in total

Review 1.  Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.

Authors:  Ru Wen; Afoma C Umeano; Lily Francis; Nivita Sharma; Smanla Tundup; Shanta Dhar
Journal:  Vaccines (Basel)       Date:  2016-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.